A 2025 meta-analysis (Harrer et al.) finds psychotherapy has large effects for phobias, PTSD, OCD, and social/generalized anxiety, moderate for depression, and small but positive effects for psychosis and suicidal ideation. It also reports similar effectiveness in non‑Western and low‑/middle‑income countries compared with Western, wealthy settings.
— Quantified, cross‑disorder effect sizes and cross‑region parity can guide resource allocation, set realistic expectations, and counter claims that therapy is primarily a Western intervention.
Bob Grant
2025.12.04
72% relevant
The Nautilus article reports an empirical mechanism (failure to downshift cognitive state) that helps explain why generic interventions may fail for insomnia and points toward disorder‑specific treatments (circadian interventions, targeted CBT‑I, neuromodulation) — directly connecting to the existing idea that therapeutic effectiveness differs across conditions and must be evidence‑matched.
Yascha Mounk
2025.12.02
78% relevant
Marsh’s discussion of psychopathy as a distinct personality disorder with boldness, meanness, and disinhibition maps onto the existing idea that therapeutic effectiveness differs across diagnoses: psychopathic traits predict particular treatment challenges and require different intervention targets than, say, anxiety or depression.
Steve Stewart-Williams
2025.10.01
100% relevant
The article lists Hedges’ g values (e.g., phobias g=1.25; PTSD g=1.18; psychotic disorders g=0.32) and notes no efficacy gap between Western and non‑Western contexts.
← Back to All Ideas